EC
EcoR1 Capital
Venture CapitalActiveEcoR1 Capital is a biotech-focused investment advisory firm.
55
Investments
5
Exits
$1.5B
AUM
9.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for EcoR1 Capital.
Investment Thesis & Strategy
EcoR1 Capital invests in biotech companies across various stages, seeking to support innovative solutions in the biotech industry.
Investment Activity
Deals per year over the last 6 years
1
20187
20191
20202
20210
20221
2023Portfolio Companies
Selected investments from their portfolio of 55 companies
A
Alumis
Biotech · Series A, 2023
T
Tessera Therapeutics
Biotech · Series A, 2021
K
Kyverna Therapeutics
Biotech · Series A, 2021
A
Affini-T Therapeutics
Biotech · Series A, 2020
X
Xilio Therapeutics
Biotech · Series A, 2019
V
Verve Therapeutics
Biotech · Series A, 2019
C
Century Therapeutics
Biotech · Series A, 2019
C
Cellarity
Biotech · Series A, 2019
V
Vor Biopharma
Biotech · Series A, 2019
K
Kronos Bio
Biotech · Series A, 2019
S
Sana Biotechnology
Biotech · Series A, 2019
C
Carmot Therapeutics
Biotech · Series A, 2018
Notable Exits
CompanyTypeYearValue / Acquirer
Obsidian TherapeuticsAcquisition2024—
Turning Point TherapeuticsIPO2021$3B
Revolution MedicinesIPO2020$2.3B
Gossamer BioIPO2019$276M
Kura OncologyIPO2015$100M
Frequently Asked Questions
EcoR1 Capital focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Index Ventures
San Francisco, United States · 827 deals
First Round Capital
San Francisco, United States · 742 deals
Benchmark
San Francisco, United States · 600 deals
Founders Fund
San Francisco, United States · 564 deals
Matrix Partners
San Francisco, United States · 549 deals
Bain Capital Ventures
San Francisco, United States · 438 deals